tradingkey.logo
tradingkey.logo
Search

Bone Biologics Corp

BBLG
Add to Watchlist
0.850USD
-0.010-1.17%
Close 07-31 16:00ETQuotes delayed by 15 min
1.53MMarket Cap
LossP/E TTM

BBLG Financials

See Bone Biologics Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bone Biologics Corp Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.43/-0.54
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.65
90.86%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
77.74%-0.43
89.68%-0.38
97.39%-0.37
67.01%-1.33
75.61%-1.92
81.82%-3.68
51.65%-14.21
95.04%-4.02
97.63%-7.86
-123.05%-20.25
---29.40
---81.11
---331.50
--87.88
---55.14
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
24.69%-765.99K
55.01%-684.64K
83.95%-666.74K
5.51%-740.52K
-17.45%-1.02M
1.82%-1.52M
-116.36%-4.15M
55.70%-783.73K
76.66%-865.97K
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
602.69%893.46K
-139.40%-1.22M
4.59%-469.30K
-59.70%-689.50K
60.83%-177.74K
-29.25%-509.30K
-29.44%-491.90K
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
22.48%-805.05K
52.85%-733.11K
24.79%-715.27K
7.61%-748.08K
-14.94%-1.04M
-34.05%-1.55M
54.30%-951.02K
73.37%-809.66K
71.29%-903.54K
9.99%-1.16M
-70.67%-2.08M
-547.74%-3.04M
-379.50%-3.15M
-179.86%-1.29M
-430.61%-1.22M
-102.39%-469.30K
-262.82%-656.42K
-123.07%-460.48K
-57.58%-229.79K
-74.73%-231.88K
Net Profit
24.69%-765.99K
55.01%-684.64K
83.95%-666.74K
5.51%-740.52K
-17.45%-1.02M
1.82%-1.52M
-116.36%-4.15M
55.70%-783.73K
76.66%-865.97K
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
602.69%893.46K
-139.40%-1.22M
4.59%-469.30K
-59.70%-689.50K
60.83%-177.74K
-29.25%-509.30K
-29.44%-491.90K
Current assets
57.47%4.98M
50.11%5.80M
56.20%6.35M
119.27%7.00M
-17.65%3.16M
3.31%3.86M
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
-56.00%3.74M
-4.32%4.98M
34.71%7.62M
11.32%6.78M
27.26%8.50M
9826.85%5.20M
127409.71%5.66M
8462.80%6.09M
--6.68M
2028.93%52.39K
209.70%4.44K
Total current liabilities
23.18%309.39K
10.82%418.59K
22.27%334.28K
42.75%406.14K
52.56%251.16K
-54.57%377.71K
-76.89%273.40K
-85.26%284.51K
-95.90%164.63K
-67.37%831.40K
48.00%1.18M
2632.68%1.93M
7204.93%4.01M
2450.25%2.55M
-94.73%799.48K
-99.52%70.64K
-99.61%54.91K
-99.27%99.91K
14.63%15.18M
13.81%14.62M
Total assets
57.47%4.98M
50.11%5.80M
56.20%6.35M
119.27%7.00M
-17.65%3.16M
3.31%3.86M
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
-56.00%3.74M
-4.32%4.98M
34.71%7.62M
11.32%6.78M
27.26%8.50M
9826.85%5.20M
127409.71%5.66M
8462.80%6.09M
--6.68M
2028.93%52.39K
209.70%4.44K
Total liabilities
23.18%309.39K
10.82%418.59K
22.27%334.28K
42.75%406.14K
52.56%251.16K
-54.57%377.71K
-76.89%273.40K
-85.26%284.51K
-95.90%164.63K
-67.37%831.40K
48.00%1.18M
2632.68%1.93M
7204.93%4.01M
2450.25%2.55M
-94.73%799.48K
-99.52%70.64K
-99.61%54.91K
-99.27%99.91K
14.63%15.18M
13.81%14.62M
Total equity
60.43%4.67M
54.37%5.38M
58.65%6.02M
126.75%6.60M
-20.79%2.91M
19.86%3.48M
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
-51.13%2.91M
-13.82%3.79M
1.87%5.69M
-54.09%2.77M
-9.55%5.95M
129.10%4.40M
138.23%5.59M
142.76%6.04M
148.02%6.58M
-14.25%-15.13M
-13.79%-14.62M
Net operating income
13.16%-804.28K
47.19%-714.76K
-3.36%-591.38K
48.78%-458.88K
28.95%-926.13K
32.93%-1.35M
77.61%-572.16K
75.34%-895.87K
3.45%-1.30M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
-572.57%-860.78K
-48.66%-186.85K
-284.57%-277.77K
-703.68%-635.98K
Net financing
----
-100.00%0.00
-100.00%0.00
1455683.28%4.35M
-76.90%347.55K
87.87%1.11M
--1.81M
-99.99%299.00
--1.50M
-86.64%592.00K
--0.00
--4.45M
----
-35.41%4.43M
-100.00%0.00
-100.00%0.00
-100.00%0.00
5465.80%6.86M
270.48%276.71K
642.16%569.25K

FAQs

What are the current assets of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its current assets were 5.80M, with a year-on-year change of 50.11.

What are the total assets of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its total assets of Bone Biologics Corp were 5.80M, with a year-on-year change of 50.11.

What are the total liabilities of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its total liabilities of Bone Biologics Corp were 418.59K, with a year-on-year change of 10.82.

What is the total equity of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its total equity of Bone Biologics Corp was 5.38M, with a year-on-year change of 54.37.

What is the net operating income of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its net operating income of Bone Biologics Corp was -3.23M, with a year-on-year change of 23.33.

What is the net financing of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its net financing of Bone Biologics Corp was 4.70M, with a year-on-year change of 6.26.

What is the Earnings Per Share (EPS) of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -2.65, with a year-on-year change of 90.86.

What is the net income of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its net income was -3.11M, with a year-on-year change of 57.56.

What is the Return on Equity (ROE) of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its Return on Equity (ROE) was -70.17, with a year-on-year change of 69.39.

What is the Return on Assets (ROA) of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its Return on Assets (ROA) was -64.38, with a year-on-year change of 40.51.

What is the operating profit of Bone Biologics Corp?

According to Bone Biologics Corp's FY2025 earnings report, its operating profit was -3.23M, with a year-on-year change of 23.33.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.